These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6235723)

  • 1. Current theories on the mode of action of antidepressant drugs.
    Carlsson A
    Adv Biochem Psychopharmacol; 1984; 39():213-21. PubMed ID: 6235723
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent observations on new potential and established antidepressant drugs.
    Carlsson A
    Pharmacopsychiatria; 1982 Jul; 15(4):116-20. PubMed ID: 6216489
    [No Abstract]   [Full Text] [Related]  

  • 3. The interactions of tricyclic antidepressants with the biogenic amine uptake systems in the central nervous system.
    Horn AS
    Postgrad Med J; 1976; 52(3 suppl):25-32. PubMed ID: 785422
    [No Abstract]   [Full Text] [Related]  

  • 4. Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine.
    Jolas T; Haj-Dahmane S; Kidd EJ; Langlois X; Lanfumey L; Fattaccini CM; Vantalon V; Laporte AM; Adrien J; Gozlan H
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1432-43. PubMed ID: 8138956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of brain serotonergic receptor mechanisms for the action of antidepressant drugs.
    Ogren SO; Fuxe K; Agnati L
    Pharmacopsychiatry; 1985 Mar; 18(2):209-13. PubMed ID: 3927330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The biochemistry of depression.
    Gordon AM
    J Int Med Res; 1977; 5 Suppl 4():81-4. PubMed ID: 563350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-Hydroxy-2-methyl-2-(di-n-propylamino)tetralin: synthesis and central pharmacological effects.
    Hacksell U; Arvidsson LE; Johansson AM; Nilsson JL; Sanchez D; Andersson B; Lindberg P; Wikström H; Hjorth S; Svensson K
    Acta Pharm Suec; 1985; 22(2):65-74. PubMed ID: 2996294
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacologic mechanisms of action of antidepressants.
    Frazer A; Conway P
    Psychiatr Clin North Am; 1984 Sep; 7(3):575-86. PubMed ID: 6091070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant-like properties of some serotonin receptor ligands and calcium channel antagonists measured with the forced swimming test in mice.
    Biała G
    Pol J Pharmacol; 1998; 50(2):117-24. PubMed ID: 9798263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mode of action of tricyclic antidepressants].
    Carlsson A
    Tidsskr Nor Laegeforen; 1973 Jun; 93(17):1300-2. PubMed ID: 4356436
    [No Abstract]   [Full Text] [Related]  

  • 12. Some biochemical properties of the new potential antidepressant agent N-methyl-N-propargyl-2-(1-methyl-5-methoxyindolyl)methylamine.
    Carranza Gómez-Carpintero M; Ochoa Estomba MC
    Arzneimittelforschung; 1993 Sep; 43(9):937-41. PubMed ID: 8240453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antidepressant treatments on 5-HT neurotransmission: electrophysiological and clinical studies.
    de Montigny C; Blier P
    Adv Biochem Psychopharmacol; 1984; 39():223-39. PubMed ID: 6087626
    [No Abstract]   [Full Text] [Related]  

  • 14. New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl)N- propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(+/-)-S 20244] and its enantiomers, (+)-S 20499 and (-)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptors.
    Kidd EJ; Haj-Dahmane S; Jolas T; Lanfumey L; Fattaccini CM; Guardiola-Lemaitre B; Gozlan H; Hamon M
    J Pharmacol Exp Ther; 1993 Feb; 264(2):863-72. PubMed ID: 8094756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged treatment with antidepressants increases the 5-HT1A-mediated inhibition of hippocampal neurons without changing the 5-HT1A receptor binding.
    Tokarski K; Czyrak A; Maćkowiak M; Wedzony K; Bijak M
    Acta Physiol Hung; 1996; 84(3):343-4. PubMed ID: 9219632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving concepts on the interactions between antidepressant treatments and monoamine neurotransmitters.
    Green AR
    Neuropharmacology; 1987 Jul; 26(7B):815-22. PubMed ID: 2889156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tricyclic antidepessants on attack elicited by hypothalamic stimulation: relation to brain biogenic amines.
    Dubinsky B; Karpowicz JK; Goldberg ME
    J Pharmacol Exp Ther; 1973 Dec; 187(3):550-7. PubMed ID: 4272322
    [No Abstract]   [Full Text] [Related]  

  • 18. The mode of action of tricyclic antidepressants: a brief review of recent progress.
    Horn AS
    Postgrad Med J; 1980; 56 Suppl 1():9-12. PubMed ID: 6248847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of clomipramine and other tricyclic antidepressants on biogenic amine uptake and turnover.
    Waldmeier PC; Baumann P; Greengrass PM; Maître L
    Postgrad Med J; 1976; 52(3 suppl):33-9. PubMed ID: 785423
    [No Abstract]   [Full Text] [Related]  

  • 20. Antidepressant-like effects of novel triple reuptake inhibitors, PRC025 and PRC050.
    Shaw AM; Boules M; Zhang Y; Williams K; Robinson J; Carlier PR; Richelson E
    Eur J Pharmacol; 2007 Jan; 555(1):30-6. PubMed ID: 17109850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.